US Broker Ratings

TG Therapeutics, Inc. (TGTX) Stock Analysis: A 50% Upside Potential in Biotech

TG Therapeutics, Inc. (NASDAQ: TGTX) stands out in the biotechnology sector with a market capitalization of $4.69 billion, making it an intriguing prospect for investors seeking exposure to the healthcare..

Inspire Medical Systems, Inc. (INSP) Stock Analysis: A Potential 30.79% Upside in the Healthcare Sector

Inspire Medical Systems, Inc. (NASDAQ: INSP), a prominent player in the healthcare sector, specializes in the development of innovative medical devices, particularly for patients suffering from obstructive sleep apnea (OSA)...

Nuvalent, Inc. (NUVL) Stock Analysis: Exploring a 41.94% Potential Upside Amidst Strong Buy Ratings

Nuvalent, Inc. (NASDAQ: NUVL) is drawing significant attention in the biotechnology sector with its promising pipeline and robust analyst support. The clinical-stage biopharmaceutical company, headquartered in Cambridge, Massachusetts, is focused..

BrightSpring Health Services (BTSG): Analyst Consensus Reveals Strong Buy Ratings and 8.3% Upside Potential

BrightSpring Health Services, Inc. (BTSG), a formidable player in the U.S. healthcare market, operates within the Health Information Services industry. With a market capitalization of $7.41 billion, the company has..

Legend Biotech Corporation (LEGN): Analyst Consensus Highlights 248% Potential Upside

Legend Biotech Corporation (NASDAQ: LEGN), a dynamic player in the biotechnology sector, is drawing attention with its significant potential upside of 248.08%, as revealed by recent analyst ratings. As a..

Avidity Biosciences, Inc. (RNA) Stock Analysis: Exploring Growth Potential Amidst 434% Revenue Surge

Avidity Biosciences, Inc. (NASDAQ: RNA) is capturing the attention of investors with its remarkable 434% revenue growth, underscoring its potential in the burgeoning biotechnology sector. As a biopharmaceutical company specializing..

Sarepta Therapeutics, Inc. (SRPT): Investor Outlook on Promising Gene Therapy Potential and 13.53% Upside

Sarepta Therapeutics, Inc. (NASDAQ: SRPT) stands at the forefront of the biotechnology sector with its innovative RNA-targeted therapeutics and gene therapies aimed at treating rare diseases like Duchenne muscular dystrophy...

Viatris Inc. (VTRS) Investor Outlook: Navigating a 3.02% Dividend Yield Amidst Healthcare Opportunities

For individual investors eyeing the healthcare sector, Viatris Inc. (NASDAQ: VTRS) presents an intriguing case. With a market capitalization of $18.38 billion, Viatris operates as a major player in the..

Jazz Pharmaceuticals (JAZZ) Stock Analysis: A 27% Upside Potential with Robust Growth Prospects

Jazz Pharmaceuticals plc (NASDAQ: JAZZ), a prominent player in the biotechnology sector, is capturing investor attention with a promising upside potential of 27.42%. Headquartered in Dublin, Ireland, Jazz Pharmaceuticals is..

Rhythm Pharmaceuticals, Inc. (RYTM) Stock Analysis: Exploring a 42.11% Upside Potential with a Strong Buy Consensus

Rhythm Pharmaceuticals, Inc. (NASDAQ: RYTM) stands out in the biotechnology sector, capturing investor attention with its focus on rare neuroendocrine diseases. Headquartered in Boston, Massachusetts, this commercial-stage biopharmaceutical company is..

Halozyme Therapeutics (HALO) Stock Analysis: Strong Revenue Growth and Significant Upside Potential

Halozyme Therapeutics, Inc. (NASDAQ: HALO), a prominent player in the biotechnology sector, has captured investor attention with its innovative approach to drug delivery and impressive financial metrics. With a market..

Oscar Health, Inc. (OSCR) Stock Analysis: Navigating a 16.4% Potential Upside Amidst Market Volatility

Oscar Health, Inc. (NYSE: OSCR), a healthcare technology company, presents a compelling opportunity for investors who are keen to explore the evolving landscape of healthcare plans in the United States...

Stevanato Group S.p.A. (STVN) Stock Analysis: Unveiling a 73% Potential Upside in the Healthcare Sector

For investors with an eye for opportunity in the healthcare sector, Stevanato Group S.p.A. (NYSE: STVN) presents a compelling case. Headquartered in Italy, this company operates within the medical instruments..

Henry Schein, Inc. (HSIC) Stock Analysis: A Comprehensive Look at Growth Potential Amidst Healthcare Distribution Dynamics

Henry Schein, Inc. (NASDAQ: HSIC), a prominent player in the medical distribution sector, has carved out a significant niche by providing a wide array of healthcare products and services. With..

Globus Medical, Inc. (GMED): Investor Outlook and Growth Potential Amid Strong Analyst Consensus

Globus Medical, Inc. (NYSE: GMED), a prominent player in the healthcare sector, is making waves in the medical devices industry with its innovative solutions for musculoskeletal disorders. Headquartered in Audubon,..

Krystal Biotech, Inc. (KRYS) Stock Analysis: An Investor’s Guide to a Promising 17% Upside

Krystal Biotech, Inc. (NASDAQ: KRYS), a dynamic player in the biotechnology sector, presents an intriguing opportunity for investors seeking exposure to the healthcare market’s innovative edge. With a market capitalization..

Telix Pharmaceuticals Limited (TLX) Stock Report: Unpacking a 183.83% Upside Potential

Telix Pharmaceuticals Limited (ASX: TLX), an innovative player in the biotechnology sector, is captivating investor attention with its robust pipeline of diagnostic and therapeutic radiopharmaceuticals. Headquartered in North Melbourne, Australia,..

Bio-Rad Laboratories, Inc. (BIO) Stock Analysis: Exploring a 19.42% Potential Upside in the Healthcare Sector

Bio-Rad Laboratories, Inc. (NYSE: BIO), a stalwart in the healthcare sector, is making waves in the investor community with a promising potential upside of 19.42%. With a market capitalization of..

Regencell Bioscience Holdings (RGC) Stock Analysis: Navigating the Volatility in a $14.42 Billion Healthcare Innovator

Regencell Bioscience Holdings Limited (NASDAQ: RGC), a Hong Kong-based Traditional Chinese Medicine (TCM) bioscience company, stands at the intersection of healthcare innovation and market volatility. With a market capitalization of..

Integer Holdings Corporation (ITGR) Stock Analysis: Uncovering an 8% Potential Upside in the Medical Devices Sector

As investors navigate the dynamic landscape of the healthcare sector, Integer Holdings Corporation (NYSE: ITGR) emerges as a noteworthy player in the medical devices industry. With a market capitalization of..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds